Your Guide to Better Health

Peptides for long COVID recovery are gaining serious clinical attention. This deep dive covers what BPC-157, Thymosin Alpha-1, and TB-500 research shows about post-viral fatigue, immune dysfunction, brain fog, and cardiovascular damage — and what a clinician-supervised protocol looks like.

Gut brain axis peptides BPC-157 and KPV are emerging at the intersection of gut inflammation and neurological health. This deep dive covers how each peptide acts on the gut-brain connection, what the research shows, and what a clinical assessment looks like.

GLP-1 peptides cardiovascular heart health benefits go far beyond weight loss. New data from the SELECT and SURPASS-CVOT trials shows 20%+ reduction in heart attacks and strokes. This deep dive breaks down the mechanisms, the outcomes data, and what it means for high-risk patients.

Peptide therapy not working as expected? This article breaks down 10 clinically grounded reasons your protocol may be stalling — from sourcing and dosing to timing, lifestyle gaps, and receptor fatigue.

Peptide therapy for adults over 60 can restore GH signalling, reduce visceral fat, and slow sarcopenia — but seniors need lower doses, tighter monitoring, and mandatory cancer screening. This pillar guide covers the best peptides for elderly metabolic health, the real risks, and how to access care safely.

Peptides for men over 40 hormonal health explained by clinicians. This guide covers CJC-1295/ipamorelin, sermorelin, tesamorelin, BPC-157, and PT-141 — with evidence-based protocols, realistic outcome timelines, and the baseline labs every man should order before starting.

Semax and selank cognitive peptides are at the centre of a major 2026 regulatory shift. This pillar guide breaks down how each peptide works, what the clinical evidence actually shows, where the regulatory line sits today, and how to pursue a supervised protocol that is both legal and evidence-informed.

MOTS-c exercise mimetic peptide research is reshaping how clinicians think about sedentary metabolic decline. This article breaks down the AMPK science, what preclinical and human data actually show, and why this matters for metabolically compromised adults who struggle to exercise.

Wondering how to start peptide therapy but don't know where to begin? This complete beginner's guide covers baseline labs, choosing a qualified clinician, selecting the right peptide for your goal, sourcing safely, and what to expect in your first 12 weeks — all backed by clinical evidence.

Shopping for the best peptide therapy provider comparison in 2026? This guide covers the 6 non-negotiables every legitimate clinic must meet, how telehealth compares to in-person care, what insurance actually covers, and how to spot red flags before you book.

Growth hormone peptide therapy results are measurable — and they show up on labs. This case study walks through 12 weeks of a CJC-1295/ipamorelin protocol in a metabolic patient: baseline biomarkers, week-by-week timeline, and the final numbers across IGF-1, HOMA-IR, triglycerides, and fasting insulin. If you want to know what real outcomes look like before you start, this is the data.

Comparing BPC-157 injection vs oral peptide delivery? This guide breaks down injectable, oral, and nasal BPC-157 by bioavailability, best use case, and clinical evidence — so you can match the method to your goal.

A clinical GLP-1 telehealth provider comparison for 2026. See how Hims, Ro, Calibrate, Mochi Health, and Meto compare on lab requirements, specialist access, monitoring cadence, and insurance coverage — before you enrol.

Low growth hormone symptoms adults often overlook include fatigue, muscle loss, poor sleep, and stubborn fat gain. Learn signs, testing, and peptide options.

This guide answers the 15 questions that come up most consistently among people seriously considering GLP-1 treatment — drawing from clinical trial data, FDA prescribing guidance, and current endocrinology practice standards. The goal is not to replace a conversation with your prescriber; it is to ensure that conversation is a productive one.

Most people starting a peptide protocol arrive at their first injection with the same uncertainty: the medication is ready, but the process isn't. This guide walks through every step of safe home injection — supplies, reconstitution, needle selection, site rotation, and what to do when something goes wrong.

MiO is not inherently harmful when used occasionally, but it is not ideal for long-term metabolic health. It contains artificial sweeteners like sucralose and acesulfame potassium, which may affect gut bacteria, insulin response, and taste preferences over time.

Breaking a fast the wrong way can trigger sharp glucose spikes and undo metabolic benefits. This guide explains exactly what to eat, in what order, and why it matters.